{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T16:54:25Z","timestamp":1775494465472,"version":"3.50.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Biochem Biophys"],"DOI":"10.1007\/s12013-025-01901-4","type":"journal-article","created":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T07:41:52Z","timestamp":1758872512000},"page":"847-871","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["In-silico and In-vitro Gene Expression Analysis on Docetaxel and Methotrexate-induced Cytotoxicity in Oral Cancer Cell Line"],"prefix":"10.1007","volume":"84","author":[{"given":"Maheshvare","family":"Natesan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rubin Nishanth","family":"Armstrong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krithika","family":"Narayanan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brindha","family":"G.R","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Devipriya","family":"Nagarajan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arpit","family":"Sikri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rekha","family":"Arcot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muthu","family":"Thiruvengadam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naiyf S","family":"Alharbi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,26]]},"reference":[{"key":"1901_CR1","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.3390\/pharmaceutics15061653","volume":"15","author":"JPN Silva","year":"2023","unstructured":"Silva, J. P. N., Pinto, B., Monteiro, L., Silva, P. M. A., & Bousbaa, H. (2023). Combination therapy as a promising way to fight oral cancer. Pharmaceutics, 15, 1653. https:\/\/doi.org\/10.3390\/pharmaceutics15061653","journal-title":"Pharmaceutics"},{"key":"1901_CR2","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1177\/00220345211014795","volume":"100","author":"S Warnakulasuriya","year":"2021","unstructured":"Warnakulasuriya, S., & Kerr, A. R. (2021). Oral cancer screening: Past, present, and future. Journal of Dental Research, 100, 1313\u20131320. https:\/\/doi.org\/10.1177\/00220345211014795","journal-title":"Journal of Dental Research"},{"key":"1901_CR3","doi-asserted-by":"publisher","first-page":"825266","DOI":"10.3389\/fphar.2022.825266","volume":"13","author":"P Kumari","year":"2022","unstructured":"Kumari, P., Debta, P., & Dixit, A. (2022). Oral potentially malignant disorders: Etiology, pathogenesis, and transformation into oral cancer. Frontiers in Pharmacology, 13, 825266. https:\/\/doi.org\/10.3389\/fphar.2022.825266","journal-title":"Frontiers in Pharmacology"},{"key":"1901_CR4","doi-asserted-by":"publisher","unstructured":"Huang, S., & Sullivan, O., B (2013). Oral cancer: Current role of radiotherapy and chemotherapy. Medicina Oral Patolog\u00eda Oral Y Cirugia Bucal, e233\u2013e240. https:\/\/doi.org\/10.4317\/medoral.18772","DOI":"10.4317\/medoral.18772"},{"key":"1901_CR5","doi-asserted-by":"publisher","first-page":"e389810","DOI":"10.1200\/EDBK_389810","volume":"43","author":"I Mohamad","year":"2023","unstructured":"Mohamad, I., Glaun, M. D. E., Prabhash, K., Busheri, A., Lai, S. Y., Noronha, V., & Hosni, A. (2023). Current treatment strategies and risk stratification for oral carcinoma. American Society of Clinical Oncology Educational Book, 43, e389810. https:\/\/doi.org\/10.1200\/EDBK_389810","journal-title":"American Society of Clinical Oncology Educational Book"},{"key":"1901_CR6","doi-asserted-by":"publisher","first-page":"e30226","DOI":"10.7759\/cureus.30226","volume":"14","author":"SM Alsaeedi","year":"2022","unstructured":"Alsaeedi, S. M., & Aggarwal, S. (2022). The holistic review on occurrence, biology, diagnosis, and treatment of oral squamous cell carcinoma. Cureus, 14, e30226. https:\/\/doi.org\/10.7759\/cureus.30226","journal-title":"Cureus"},{"key":"1901_CR7","doi-asserted-by":"publisher","first-page":"893","DOI":"10.3390\/biom11060893","volume":"11","author":"J Sha","year":"2021","unstructured":"Sha, J., Bai, Y., Ngo, H. X., Okui, T., & Kanno, T. (2021). Overview of Evidence-Based chemotherapy for oral cancer: Focus on drug resistance related to the Epithelial-Mesenchymal transition. Biomolecules, 11, 893. https:\/\/doi.org\/10.3390\/biom11060893","journal-title":"Biomolecules"},{"key":"1901_CR8","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s12291-022-01055-7","volume":"38","author":"P Gupta","year":"2023","unstructured":"Gupta, P., Singh, A., Verma, A. K., Kant, S., Pandey, A. K., Mishra, A., Khare, P., & Prakash, V. (2023). Nanoencapsulation of docetaxel induces concurrent apoptosis and necroptosis in human oral cancer cells (SCC-9) via TNF-\u03b1\/RIP1\/RIP3 pathway. Indian Journal of Clinical Biochemistry, 38, 351\u2013360. https:\/\/doi.org\/10.1007\/s12291-022-01055-7","journal-title":"Indian Journal of Clinical Biochemistry"},{"key":"1901_CR9","doi-asserted-by":"publisher","first-page":"13857","DOI":"10.3390\/ijms232213857","volume":"23","author":"CC Su","year":"2022","unstructured":"Su, C. C., Lin, J. W., Chang, K. Y., Wu, C. T., Liu, S. H., Chang, K. C., Liu, J. M., Lee, K. I., Fang, K. M., & Chen, Y. W. (2022). Involvement of AMPK\u03b1 and MAPK-ERK\/-JNK signals in Docetaxel-Induced human tongue squamous cell carcinoma cell apoptosis. International Journal of Molecular Sciences, 23, 13857. https:\/\/doi.org\/10.3390\/ijms232213857","journal-title":"International Journal of Molecular Sciences"},{"key":"1901_CR10","doi-asserted-by":"publisher","first-page":"530","DOI":"10.4103\/2221-1691.363879","volume":"12","author":"S Samal","year":"2022","unstructured":"Samal, S., Meher, R. K., Dubey, D., Mir, S. A., Nayak, B., Sahu, M. C., Naik, P. K., Rath, G., & Swain, S. K. (2022). In-silico and in-vitro evaluation of docetaxel and Berberine as potential p53 modulating apoptotic inducers in oral squamous cell carcinoma. Asian Pacific Journal of Tropical Biomedicine, 12, 530\u2013540. https:\/\/doi.org\/10.4103\/2221-1691.363879","journal-title":"Asian Pacific Journal of Tropical Biomedicine"},{"key":"1901_CR11","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/s41584-020-0373-9","volume":"16","author":"BN Cronstein","year":"2020","unstructured":"Cronstein, B. N., & Aune, T. M. (2020). Methotrexate and its mechanisms of action in inflammatory arthritis. Nature Reviews Rheumatology, 16, 145\u2013154. https:\/\/doi.org\/10.1038\/s41584-020-0373-9","journal-title":"Nature Reviews Rheumatology"},{"key":"1901_CR12","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s13193-018-0846-3","volume":"10","author":"A Deshpande","year":"2019","unstructured":"Deshpande, A., Nandu, V. V., & Jadhav, J. (2019). Role of Single-Agent methotrexate as a neoadjuvant chemotherapy in oral cavity cancers. Indian Journal of Surgical Oncology, 10, 125\u2013129. https:\/\/doi.org\/10.1007\/s13193-018-0846-3","journal-title":"Indian Journal of Surgical Oncology"},{"key":"1901_CR13","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1007\/s12663-023-01963-y","volume":"23","author":"NAN Kumar","year":"2024","unstructured":"Kumar, N. A. N., Dikhit, P. S., Jose, A., Mehta, V., Pai, A., Kudva, A., & Rao, M. (2024). Oral metronomic chemotherapy in advanced and metastatic oral squamous cell carcinoma: A need of the hour. Journal of Maxillofacial and Oral Surgery, 23, 793\u2013800. https:\/\/doi.org\/10.1007\/s12663-023-01963-y","journal-title":"Journal of Maxillofacial and Oral Surgery"},{"key":"1901_CR14","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.3332\/ecancer.2021.1325","volume":"15","author":"L Kashyap","year":"2021","unstructured":"Kashyap, L., Patil, V., Noronha, V., Joshi, A., Menon, N., Jobanputra, K., Saha, S., Chaturvedi, P., Banavali, S. D., & Prabhash, K. (2021). Efficacy and safety of neoadjuvant chemotherapy (NACT) with Paclitaxel plus carboplatin and oral metronomic chemotherapy (OMCT) in patients with technically unresectable oral squamous cell carcinoma (OSCC). Ecancermedicalscience, 15, 1325. https:\/\/doi.org\/10.3332\/ecancer.2021.1325","journal-title":"Ecancermedicalscience"},{"key":"1901_CR15","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s12668-025-01833-6","volume":"15","author":"S Shah","year":"2025","unstructured":"Shah, S., Famta, P., Kumar, R., Vambhurkar, G., et al. (2025). QbD manoeuvred niclosamide laden Polylactic-co-Glycolic acid Nanoparticles-Impregnated gelatin nanofibers for the management of oral carcinoma. BioNanoScience, 15, 221. https:\/\/doi.org\/10.1007\/s12668-025-01833-6","journal-title":"BioNanoScience"},{"key":"1901_CR16","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s11033-024-09407-7","volume":"51","author":"JZ Tayyeb","year":"2024","unstructured":"Tayyeb, J. Z., Priya, M., Guru, A., et al. (2024). Multifunctional Curcumin mediated zinc oxide nanoparticle enhancing biofilm Inhibition and targeting apoptotic specific pathway in oral squamous carcinoma cells. Molecular Biology Reports, 51, 423. https:\/\/doi.org\/10.1007\/s11033-024-09407-7","journal-title":"Molecular Biology Reports"},{"key":"1901_CR17","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1177\/09731296241275740","volume":"21","author":"A Alqarni","year":"2024","unstructured":"Alqarni, A., Hosmani, J., Mohammed, R., et al. (2024). Shilajit (Mumio) elicits apoptosis and suppresses cell migration in oral cancer cells through targeting Urokinase-type plasminogen activator and its receptor and chemokine signaling pathways. Pharmacognosy Magazine, 21, 491\u2013506. https:\/\/doi.org\/10.1177\/09731296241275740","journal-title":"Pharmacognosy Magazine"},{"key":"1901_CR18","doi-asserted-by":"publisher","first-page":"104457","DOI":"10.1016\/j.pdpdt.2024.104457","volume":"51","author":"SM Goujani","year":"2025","unstructured":"Goujani, S. M., Koopaie, M., Safarian, F. H., Hakimiha, N., & Younespour, S. (2025). Comparative analysis of combined methylene blue photodynamic therapy and doxorubicin treatment of oral squamous cell carcinoma cell line: In vitro study on apoptosis. Photodiagnosis and Photodynamic Therapy, 51, 104457. https:\/\/doi.org\/10.1016\/j.pdpdt.2024.104457","journal-title":"Photodiagnosis and Photodynamic Therapy"},{"key":"1901_CR19","doi-asserted-by":"publisher","first-page":"138976","DOI":"10.1016\/j.ijbiomac.2024.138976","volume":"290","author":"P Patrojanasophon","year":"2025","unstructured":"Patrojanasophon, P., Singpanna, K., Rojanarata, T., Opanasopit, P., Ngawhirunpat, T., Pengnam, S., & Pornpitchanarong, C. (2025). Folate receptor-targeted thiol-maleimide clicked chitosan\/carboxymethyl cellulose nanoparticles for cisplatin delivery in oral carcinoma. International Journal of Biological Macromolecules, 290, 138976. https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.138976","journal-title":"International Journal of Biological Macromolecules"},{"key":"1901_CR20","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.freeradbiomed.2024.04.235","volume":"220","author":"FC Chiu","year":"2024","unstructured":"Chiu, F. C., Kuo, H. M., Yu, C. L., Selvam, P., Su, I. L., Tseng, C. C., Yuan, C. H., & Wen, Z. H. (2024). Marine-derived antimicrobial peptide piscidin-1 triggers extrinsic and intrinsic apoptosis in oral squamous cell carcinoma through reactive oxygen species production and inhibits angiogenesis. Free Radical Biology and Medicine, 220, 28\u201342. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2024.04.235","journal-title":"Free Radical Biology and Medicine"},{"key":"1901_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/etm.2025.12861","volume":"29","author":"W Lin","year":"2025","unstructured":"Lin, W., Li, Y., Huang, H., Zhao, P., Su, Y., & Fang, C. Y. (2025). Harmine hydrochloride induces G0\/G1 cell cycle arrest and apoptosis in oral squamous carcinoma cells. Experimental and Therapeutic Medicine, 29, 1\u201312. https:\/\/doi.org\/10.3892\/etm.2025.12861","journal-title":"Experimental and Therapeutic Medicine"},{"key":"1901_CR22","doi-asserted-by":"publisher","first-page":"27157","DOI":"10.1038\/s41598-025-11565-y","volume":"15","author":"Y He","year":"2025","unstructured":"He, Y., Gong, X., Tao, H., et al. (2025). The effect of postoperative adjuvant chemotherapy on survival outcomes in patients with early stage oral squamous cell carcinoma. Scientific Reports, 15, 27157. https:\/\/doi.org\/10.1038\/s41598-025-11565-y","journal-title":"Scientific Reports"},{"key":"1901_CR23","doi-asserted-by":"publisher","first-page":"3294","DOI":"10.18632\/oncotarget.26908","volume":"10","author":"A Carretero-Gonz\u00e1lez","year":"2019","unstructured":"Carretero-Gonz\u00e1lez, A., Lora, D., Ghanem, I., Otero, I., L\u00f3pez, F., Castellano, D., & de Velasco, G. (2019). Comparative safety analysis of immunotherapy combined with chemotherapy versus monotherapy in solid tumors: A meta-analysis of randomized clinical trials. Oncotarget, 10, 3294\u20133301. https:\/\/doi.org\/10.18632\/oncotarget.26908","journal-title":"Oncotarget"},{"key":"1901_CR24","doi-asserted-by":"publisher","first-page":"2188","DOI":"10.21873\/invivo.13318","volume":"37","author":"M Matsuo","year":"2023","unstructured":"Matsuo, M., Masuda, M., Yamauchi, M., Taura, M., Hashimoto, K., Kogo, R., Jiromaru, R., Hongo, T., Manako, T., & Nakagawa, T. (2023). Pembrolizumab monotherapy versus pembrolizumab plus chemotherapy in patients with head and neck squamous cell carcinoma. In Vivo (Athens Greece), 37, 2188\u20132196. https:\/\/doi.org\/10.21873\/invivo.13318","journal-title":"In Vivo (Athens Greece)"},{"key":"1901_CR25","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.3390\/ijms19061698","volume":"19","author":"X Zhang","year":"2018","unstructured":"Zhang, X., Feng, H., Li, D., Liu, S., Amizuka, N., & Li, M. (2018). Identification of differentially expressed genes induced by aberrant methylation in oral squamous cell carcinomas using integrated bioinformatic analysis. International Journal of Molecular Sciences, 19, 1698. https:\/\/doi.org\/10.3390\/ijms19061698","journal-title":"International Journal of Molecular Sciences"},{"key":"1901_CR26","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s43042-025-00702-x","volume":"26","author":"J Malau","year":"2025","unstructured":"Malau, J., Rohmah, S., Meilani, N. D., Hermosaningtyas, A. A., Kasasiah, A., Rahmasari, R., Setiawan, H., Hasby, F. A., Raekiansyah, M., & Manalu, R. T. (2025). Towards personalized prostate cancer treatment with docetaxel in indonesia: A pharmacogenomics perspective. Egyptian Journal of Medical Human Genetics, 26, 63. https:\/\/doi.org\/10.1186\/s43042-025-00702-x","journal-title":"Egyptian Journal of Medical Human Genetics"},{"key":"1901_CR27","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1007\/s13233-023-00234-6","volume":"32","author":"S Manivannan","year":"2024","unstructured":"Manivannan, S., & Narayan, S. (2024). Studies on polyethylene glycol crosslinked Chitosan nanoparticles for co-delivery of docetaxel and 5-fluorouracil with synergistic effect against cancer. Macromolecular Research, 32, 371\u2013392. https:\/\/doi.org\/10.1007\/s13233-023-00234-6","journal-title":"Macromolecular Research"},{"key":"1901_CR28","doi-asserted-by":"publisher","first-page":"101959","DOI":"10.1016\/j.jddst.2020.101959","volume":"60","author":"M Imran","year":"2020","unstructured":"Imran, M., Saleem, S., Chaudhuri, A., Ali, J., & Baboota, S. (2020). Docetaxel: An update on its molecular mechanisms, therapeutic trajectory and nanotechnology in the treatment of breast, lung and prostate cancer. Journal of Drug Delivery Science and Technology, 60, 101959. https:\/\/doi.org\/10.1016\/j.jddst.2020.101959","journal-title":"Journal of Drug Delivery Science and Technology"},{"key":"1901_CR29","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.3390\/cancers15041287","volume":"15","author":"G Liu","year":"2023","unstructured":"Liu, G., Zhu, M., Zhang, M., & Pan, F. (2023). Emerging role of IGF-1 in prostate cancer: A promising biomarker and therapeutic target. Cancers, 15, 1287. https:\/\/doi.org\/10.3390\/cancers15041287","journal-title":"Cancers"},{"key":"1901_CR30","first-page":"2209","volume":"30","author":"L Xie","year":"2010","unstructured":"Xie, L., Wei, J., Qian, X., Chen, G., Yu, L., Ding, Y., & Liu, B. (2010). CXCR4, a potential predictive marker for docetaxel sensitivity in gastric cancer. Anticancer Research, 30, 2209\u20132216.","journal-title":"Anticancer Research"},{"key":"1901_CR31","doi-asserted-by":"publisher","first-page":"1571285","DOI":"10.3389\/fimmu.2025.1571285","volume":"16","author":"G Li","year":"2025","unstructured":"Li, G., Wang, J., Fang, Q., Dai, L., & Du, W. (2025). Oncologic outcomes following neoadjuvant immunochemotherapy in locally advanced oral squamous cell carcinoma. Frontiers in Immunology, 16, 1571285. https:\/\/doi.org\/10.3389\/fimmu.2025.1571285","journal-title":"Frontiers in Immunology"},{"key":"1901_CR32","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1186\/s12916-024-03541-6","volume":"22","author":"W Jiang","year":"2024","unstructured":"Jiang, W., Chen, L., Li, R., Li, J., Dou, S., Ye, L., He, Y., Tian, Z., Yao, Y., & Zhu, G. (2024). Postoperative radiotherapy with docetaxel versus cisplatin for high-risk oral squamous cell carcinoma: A randomized phase II trial with exploratory analysis of ITGB1 as a potential predictive biomarker. BMC Medicine, 22, 314. https:\/\/doi.org\/10.1186\/s12916-024-03541-6","journal-title":"BMC Medicine"},{"key":"1901_CR33","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1080\/21691401.2023.2189913","volume":"51","author":"W Khamaikawin","year":"2023","unstructured":"Khamaikawin, W., & Locharoenrat, K. (2023). Evaluation of a docetaxel-cisplatin-fluorouracil-Au complex in human oral carcinoma cell line. Artificial Cells Nanomedicine and Biotechnology, 51, 148\u2013157. https:\/\/doi.org\/10.1080\/21691401.2023.2189913","journal-title":"Artificial Cells Nanomedicine and Biotechnology"},{"key":"1901_CR34","doi-asserted-by":"publisher","first-page":"e312","DOI":"10.1002\/mco2.312","volume":"4","author":"H Ju","year":"2023","unstructured":"Ju, H., Wei, D., Wu, Y., Liu, Y., Ding, Q., Rui, M., Fan, Z., Yao, Y., Hu, J., & Ren, G. (2023). A pilot study of camrelizumab with docetaxel and cisplatin for the first line treatment in recurrent\/metastatic oral squamous cell carcinoma. MedComm, 4, e312. https:\/\/doi.org\/10.1002\/mco2.312","journal-title":"MedComm"},{"key":"1901_CR35","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s12645-025-00308-3","volume":"16","author":"J Wu","year":"2025","unstructured":"Wu, J., Du, K., Bao, Y., Xiong, M., Chen, J., Luo, Z., Zhang, D., & Shi, Y. (2025). Docetaxel-loaded pH\/ROS dual-responsive nanoparticles for the targeted treatment of gastric cancer. Cancer Nanotechnology, 16, 5. https:\/\/doi.org\/10.1186\/s12645-025-00308-3","journal-title":"Cancer Nanotechnology"},{"key":"1901_CR36","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.toxrep.2024.04.001","volume":"12","author":"X Dong","year":"2024","unstructured":"Dong, X., & Zhang, J. (2024). Maximum tolerated dose and toxicity evaluation of orally administered docetaxel granule in mice. Toxicology Reports, 12, 430\u2013435. https:\/\/doi.org\/10.1016\/j.toxrep.2024.04.001","journal-title":"Toxicology Reports"},{"key":"1901_CR37","doi-asserted-by":"publisher","first-page":"9247","DOI":"10.1038\/s41598-023-36264-4","volume":"13","author":"Y Saito","year":"2023","unstructured":"Saito, Y., Kanno, R., Takekuma, Y., Takeshita, T., Oshino, T., & Sugawara, M. (2023). High dose of dexamethasone attenuates docetaxel-induced fluid retention in breast cancer treatment. Scientific Reports, 13, 9247. https:\/\/doi.org\/10.1038\/s41598-023-36264-4","journal-title":"Scientific Reports"},{"key":"1901_CR38","doi-asserted-by":"publisher","first-page":"3741","DOI":"10.3390\/cancers13153741","volume":"13","author":"F Atrafi","year":"2021","unstructured":"Atrafi, F., Van Eerden, R. A. G., Koolen, S. L. W., De Bruijn, P., Rijcken, C. J. F., Hanssen, R., Eskens, F. A. L. M., Lolkema, M. P., Oomen-de Hoop, E., Damman, J., & Mathijssen, R. H. J. (2021). Docetaxel skin exposure and micronucleation contributes to skin toxicity caused by CPC634. Cancers, 13, 3741. https:\/\/doi.org\/10.3390\/cancers13153741","journal-title":"Cancers"},{"key":"1901_CR39","doi-asserted-by":"publisher","first-page":"124897","DOI":"10.1016\/j.ijpharm.2024.124897","volume":"667","author":"A Karimian-Shaddel","year":"2024","unstructured":"Karimian-Shaddel, A., Dadashi, H., Mashinchian, M., Mohabbat, A., Nazemiyeh, A. R., Vandghanooni, S., & Eskandani, M. (2024). Codelivery of Metformin and methotrexate with optimized Chitosan nanoparticles for synergistic triple-negative breast cancer therapy in vivo. International Journal of Pharmaceutics, 667, 124897. https:\/\/doi.org\/10.1016\/j.ijpharm.2024.124897","journal-title":"International Journal of Pharmaceutics"},{"key":"1901_CR40","doi-asserted-by":"publisher","first-page":"124311","DOI":"10.1016\/j.ijpharm.2024.124311","volume":"660","author":"J Halder","year":"2024","unstructured":"Halder, J., Dubey, D., Kanti Rajwar, T., Mishra, A., Satpathy, B., Sahoo, D., Yadav, P., Rai, N. K., Pradhan, V., Manoharadas, D., Kar, S., Ghosh, B., G., & Rath, G. (2024). Local delivery of methotrexate\/glycyrrhizin-loaded hyaluronic acid nanofiber for the management of oral cancer. International Journal of Pharmaceutics, 660, 124311. https:\/\/doi.org\/10.1016\/j.ijpharm.2024.124311","journal-title":"International Journal of Pharmaceutics"},{"key":"1901_CR41","doi-asserted-by":"publisher","first-page":"2541","DOI":"10.3892\/ol.2017.7613","volume":"15","author":"B Jin","year":"2017","unstructured":"Jin, B., Dong, X., Xu, X., & Zhang, F. (2017). Development and in\u00ef\u00bf\u00bdvitro evaluation of mucoadhesive patches of methotrexate for targeted delivery in oral cancer. Oncology Letters, 15, 2541\u20132549. https:\/\/doi.org\/10.3892\/ol.2017.7613","journal-title":"Oncology Letters"},{"key":"1901_CR42","doi-asserted-by":"publisher","unstructured":"Kakkadath, M., Naidu, D., Kanthlal, S. K., & Sharun, K. (2025). Combating Methotrexate Resistance in Cancer Treatment: A Review on Navigating Pathways and Enhancing Its Efficacy With Fat-Soluble Vitamins. Scientifica (Cairo), 2025, 8259470. https:\/\/doi.org\/10.1155\/sci5\/8259470","DOI":"10.1155\/sci5\/8259470"},{"key":"1901_CR43","doi-asserted-by":"publisher","first-page":"2606","DOI":"10.1002\/art.30457","volume":"63","author":"CF Spurlock 3rd","year":"2011","unstructured":"Spurlock, C. F. 3rd, Aune, Z. T., Tossberg, J. T., Collins, P. L., Aune, J. P., Huston, J. W. 3rd, Crooke, P. S., Olsen, N. J., & Aune, T. M. (2011). Increased sensitivity to apoptosis induced by methotrexate is mediated by JNK. Arthritis Rheumatology, 63, 2606\u20132616. https:\/\/doi.org\/10.1002\/art.30457","journal-title":"Arthritis Rheumatology"},{"issue":"1","key":"1901_CR44","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1186\/s12935-022-02676-x","volume":"22","author":"S Ghafouri-Fard","year":"2022","unstructured":"Ghafouri-Fard, S., Noie Alamdari, A., Noee Alamdari, Y., Abak, A., Hussen, B. M., Taheri, M., & Jamali, E. (2022). Role of PI3K\/AKT pathway in squamous cell carcinoma with an especial focus on head and neck cancers. Cancer Cell International, 22(1), 254. https:\/\/doi.org\/10.1186\/s12935-022-02676-x","journal-title":"Cancer Cell International"},{"key":"1901_CR45","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.3390\/ijms23031562","volume":"23","author":"S He","year":"2022","unstructured":"He, S., Chakraborty, R., & Ranganathan, S. (2022). Proliferation and apoptosis pathways and factors in oral squamous cell carcinoma. International Journal of Molecular Sciences, 23, 1562. https:\/\/doi.org\/10.3390\/ijms23031562","journal-title":"International Journal of Molecular Sciences"},{"key":"1901_CR46","doi-asserted-by":"crossref","unstructured":"Ren, X., & Luo, W. (2019). Exploration of pro-apoptotic effect of Thymoquinone on oral squamous cell carcinoma cells through PI3K\/Akt signaling pathway. Cellular and Molecular Biology (Noisy-Le-Grand, France), 65, 61\u201364.","DOI":"10.14715\/cmb\/2019.65.1.11"},{"key":"1901_CR47","doi-asserted-by":"publisher","first-page":"2673","DOI":"10.3390\/ijms24032673","volume":"24","author":"S Pomella","year":"2023","unstructured":"Pomella, S., Cassandri, M., Melaiu, O., Marampon, F., Gargari, M., Campanella, V., Rota, R., & Barillari, G. (2023). DNA damage response gene signature as potential treatment markers for oral squamous cell carcinoma. International Journal of Molecular Sciences, 24, 2673. https:\/\/doi.org\/10.3390\/ijms24032673","journal-title":"International Journal of Molecular Sciences"},{"key":"1901_CR48","doi-asserted-by":"publisher","first-page":"870055","DOI":"10.3389\/fonc.2022.870055","volume":"12","author":"T Lan","year":"2022","unstructured":"Lan, T., Ge, Q., Zheng, K., Huang, L., Yan, Y., Zheng, L., Lu, Y., & Zheng, D. (2022). FAT1 upregulates in oral squamous cell carcinoma and promotes cell proliferation via cell cycle and DNA repair. Frontiers in Oncology, 12, 870055. https:\/\/doi.org\/10.3389\/fonc.2022.870055","journal-title":"Frontiers in Oncology"},{"key":"1901_CR49","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.job.2024.09.002","volume":"66","author":"R Chakraborty","year":"2024","unstructured":"Chakraborty, R., Khodlan, P., Tay, A., & Liu, F. (2024). STAT3 interactome predicts presence of proteins that regulate immune system in oral squamous cell carcinoma. Journal of Oral Biosciences, 66, 67\u201373. https:\/\/doi.org\/10.1016\/j.job.2024.09.002","journal-title":"Journal of Oral Biosciences"},{"key":"1901_CR50","doi-asserted-by":"publisher","first-page":"100160","DOI":"10.1016\/j.oor.2024.100160","volume":"9","author":"R Chakraborty","year":"2024","unstructured":"Chakraborty, R., Darido, C., Tay, A., Zaw, T., Ranganathan, S., Liu, F., & Palmisano, G. (2024). Inhibition of anti-tumour reactivity of immune cells in the salivary gland cancer: A proteomic approach. Oral Oncology Reports, 9, 100160. https:\/\/doi.org\/10.1016\/j.oor.2024.100160","journal-title":"Oral Oncology Reports"}],"container-title":["Cell Biochemistry and Biophysics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-025-01901-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12013-025-01901-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-025-01901-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T04:45:14Z","timestamp":1772858714000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12013-025-01901-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,26]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["1901"],"URL":"https:\/\/doi.org\/10.1007\/s12013-025-01901-4","relation":{},"ISSN":["1559-0283"],"issn-type":[{"value":"1559-0283","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,26]]},"assertion":[{"value":"12 September 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}